Executive Director for the Harvard Program in Therapeutic Science
Laura currently serves as the Executive Director for the Harvard Program in Therapeutic Science (HiTS) and the HMS Laboratory of Systems Pharmacology (LSP). HiTS is a university-wide effort to address the high failure rate of pharmaceutical development by developing new computational tools and phenotyping assays to improve our understanding of human disease and drug action.
Combining a life long interest in the mechanisms of human disease and a frustration with the human capacity for analysis of large incongruent data sets, Laura joined the Harvard Medical School Initiative in Systems Pharmacology in 2012. In July 2013, the Laboratory of Systems Pharmacology opened at HMS. The LSP employs computational biology to create new models of disease mechanisms. The HMS Laboratory of Systems Pharmacology, a shared innovation space on the Harvard Medical Quadrangle, undertakes collaborative research projects with industry and regulatory partners to co-develop methods for evaluation of drug mechanism, toxicity and efficacy.